Effect of Vascular Risk Factors on the Progression of Mild Alzheimer's Disease and Lewy Body Dementia

被引:18
|
作者
Bergland, Anne Katrine [1 ,2 ]
Dalen, Ingvild [5 ]
Larsen, Alf Inge [2 ,3 ]
Aarsland, Dag [1 ,4 ]
Soennesyn, Hogne [1 ]
机构
[1] Stavanger Univ Hosp, Ctr Age Related Med, Stavanger, Norway
[2] Univ Bergen, Dept Clin Sci, Bergen, Norway
[3] Stavanger Univ Hosp, Dept Cardiol, Stavanger, Norway
[4] Kings Coll London, Inst Psychiat Psychol & Neurosci, London, England
[5] Stavanger Univ Hosp, Dept Res, Biostat Sect, Stavanger, Norway
关键词
Alzheimer's disease; dementia; Lewy body dementia; progression; vascular risk factors; WHITE-MATTER HYPERINTENSITIES; PARKINSONS-DISEASE; COGNITIVE DECLINE; RATING-SCALE; WEIGHT CHANGE; FOLLOW-UP; BODIES; SMOKING; OBESITY; MIDLIFE;
D O I
10.3233/JAD-160847
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: Vascular risk factors (VRF) are associated with an increased risk of neurodegenerative disease. Objective: To examine the association between VRF and cognitive decline in patients with Alzheimer's disease (AD) and Lewy body dementia (LBD). Methods: We included consecutive referrals with mild AD or LBD to dementia clinics in western Norway from 2005 to 2013. The Mini-Mental Status Exam (MMSE) and Clinical Dementia Rating Scale Sum of Boxes (CDR-SB) were administered at baseline and then annually for up to five years. The VRF include diabetes mellitus, hypertension, hypercholesterolemia, overweight and smoking. Generalized Estimating Equations (GEE) were used to examine the potential association between VRF scores and the change in MMSE and CDR-SB scores, adjusting for age, sex, and the apolipoprotein epsilon 4 allele (APOE4). Results: A total of 200 patients were included (113 AD, 87 LBD) (mean age 76 years, mean baseline MMSE 24.0, mean follow-up time 3.5 years). Smoking was the only VRF significantly associated with a more rapid cognitive decline, however only in the AD group. Being overweight at baseline was associated with a slower cognitive decline. Moreover, hypertension at baseline predicted a slower decline in MMSE scores. In the LBD group diabetes mellitus was found to be associated with a slower increase in CDR-SB scores. Conclusion: With the exception of smoking, VRF at time of dementia diagnosis were not associated with a more rapid cognitive decline.
引用
收藏
页码:575 / 584
页数:10
相关论文
共 50 条
  • [1] Reduced vascular risk factors in Parkinson's disease dementia and dementia with Lewy bodies compared to Alzheimer's disease
    Chan, Po-Chi
    Wei, Cheng-Yu
    Hung, Guang-Uei
    Chiu, Pai-Yi
    BRAIN AND BEHAVIOR, 2018, 8 (03):
  • [2] The progression of cognitive impairment in dementia with Lewy bodies, vascular dementia and Alzheimer's disease
    Ballard, C
    O'Brien, J
    Morris, CM
    Barber, R
    Swann, A
    Neill, D
    McKeith, I
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2001, 16 (05) : 499 - 503
  • [3] Biomarkers for the diagnosis of Alzheimer's disease, dementia Lewy body, frontotemporal dementia and vascular dementia
    Maclin, Joshua Marvin Anthony
    Wang, Tao
    Xiao, Shifu
    GENERAL PSYCHIATRY, 2019, 32 (01)
  • [4] Alzheimer's disease and Lewy body dementia
    不详
    AGE AND AGEING, 1999, 28 (03) : 251 - 251
  • [5] Progression to Dementia in Mild Cognitive Impairment With Lewy Bodies or Alzheimer Disease
    Hamilton, Calum A.
    Matthews, Fiona E.
    Donaghy, Paul C.
    Taylor, John-Paul
    O'Brien, John T.
    Barnett, Nicola
    Olsen, Kirsty
    Durcan, Rory
    Roberts, Gemma
    Ciafone, Joanna
    Barker, Sally A. H.
    Firbank, Michael
    McKeith, Ian G.
    Thomas, Alan J.
    NEUROLOGY, 2021, 96 (22) : E2685 - E2693
  • [6] Impaired imitation of gestures in mild dementia: comparison of dementia with Lewy bodies, Alzheimer's disease and vascular dementia
    Nagahama, Yasuhiro
    Okina, Tomoko
    Suzuki, Norio
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2015, 86 (11): : 1248 - 1252
  • [7] Vascular risk factors and progression in Alzheimer's disease
    Sakurai, Hirofumi
    Hanyu, Haruo
    Sato, Tomohiko
    Kanetaka, Hidekazu
    Shimizu, Soichiro
    Hirao, Kentaro
    Kikukawa, Masayuki
    Iwamoto, Toshihiko
    GERIATRICS & GERONTOLOGY INTERNATIONAL, 2011, 11 (02) : 211 - 214
  • [8] Polygenic risk discriminates Lewy body dementia from Alzheimer's disease
    Mckeever, Anna
    Swann, Peter
    Malpetti, Maura
    Donaghy, Paul C.
    Thomas, Alan
    Mak, Elijah
    Carter, Stephen F.
    Tan, Jerry H. K.
    Hong, Young T.
    Fryer, Tim D.
    Heslegrave, Amanda
    Zetterberg, Henrik
    Su, Li
    Chouliaras, Leonidas
    Rowe, James B.
    O'Brien, John T.
    ALZHEIMERS & DEMENTIA, 2025, 21 (02)
  • [9] Dementia with parkinsonism: Alzheimer's disease or Lewy body disease?
    Lippa, CF
    OConnell, B
    Nee, L
    Smith, TW
    NEUROLOGY, 1997, 48 (03) : 14005 - 14005
  • [10] Prevalence and severity of neuropsychiatric syndromes in Alzheimer's disease, vascular dementia and Lewy body disease
    Monastero, R
    Caputo, M
    Sebastiani, V
    Mariani, E
    Camarda, R
    Senin, U
    Mecocci, R
    JOURNAL OF NEUROLOGY, 2004, 251 : 38 - 39